Spinocerebellar Ataxia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA withdrawal · 2026-06-24
EMA Application withdrawn: Dazluma — Biohaven Bioscience Ireland Limited
The EMA has withdrawn the application for Dazluma for spinocerebellar ataxias.